fbpx

molecules of the month

ETX0462

penicillin-binding protein + _-lactamase inh.

preclin. eff. at 50 mpk SC, 2,000 mpk tolerated

multitarget SBDD + opt. for porin permeability

Nature

Entasis Therapeutics

Chemical structure of molecule ETX0462
3 mins read

The Entasis broad-spectrum antibiotic, ETX0462, is both an inhibitor of penicillin-binding proteins (PBPs, the target of beta-lactams) and a beta-lactamase inhibitor (BLI). Reviewer Mike Koehler thought this was a substantial disclosure. “A number of BLIs co-formulated with carbapenems and monobactams are currently on the market. There are a number of downsides to co-formulation, not the least of which is that you have to match the PK of the BLI and your beta-lactam in order to be most effective. The diazabicyclooctane (DBO) class includes avibactam, a component of AvyCaz, one of our better options for bacterial infections. Less known is the fact that DBOs can act as single agent antibiotics as well. This stems from the fact that they can inhibit penicillin-binding proteins (PBPs).…


request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.


already a member? log in: